More recently George et al. [42] achieved sustained high-level expression using a high specific activity factor IX variant, while Rangarajan et al. [43] extended AAV gene transfer success to hemophilia A, overcoming the technical challenges related to large factor VIII gene. The gene discussed is F9; the disease is hemophilia A.